Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL – Get Free Report) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 100 shares, a drop of 50.0% from the January 31st total of 200 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is presently 0.2 days.
Tema Neuroscience and Mental Health ETF Stock Down 0.8 %
MNTL stock traded down $0.21 during trading on Monday, hitting $24.65. 185 shares of the company’s stock traded hands, compared to its average volume of 610. The firm has a market capitalization of $10.85 million, a P/E ratio of 22.77 and a beta of 0.99. The business has a fifty day simple moving average of $25.01 and a two-hundred day simple moving average of $25.93. Tema Neuroscience and Mental Health ETF has a 1 year low of $23.67 and a 1 year high of $27.66.
Tema Neuroscience and Mental Health ETF Announces Dividend
The company also recently declared a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were issued a $0.257 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.
Tema Neuroscience and Mental Health ETF Company Profile
The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Recommended Stories
- Five stocks we like better than Tema Neuroscience and Mental Health ETF
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How to Invest in Insurance Companies: A Guide
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Tema Neuroscience and Mental Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.